Glaucoma Journal Club

Wendy Yee Murahashi

OpenAlexGoogle ScholarResearchGateScopus

In this database

1

2023

DB Citations

0

across indexed articles

h-index

4

OpenAlex (all works)

Total Citations

3,101

OpenAlex (all works)

8 total publications (OpenAlex)4 i10-index

1 article in Glaucoma Journal Club

Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma.

ANX007 intravitreal injections for glaucoma were well-tolerated and effectively engaged the C1q target, suggesting potential for monthly dosing. This supports further investigation in neurodegenerative eye diseases.

Ophthalmology science2023 Jun
neuroprotection